GGrantIndex
Sort

51,570 grants matching autoimmune disease

Role of TREX1 in age-related hereditary leukoencephalopathy

$791,361
Jonathan J Miner · University Of Pennsylvania · R01 · FY2023 · NS

Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)

$791,345
Caroline Helene Shiboski · University Of California, San Francisco · U01 · FY2024 · DE

Engineered Immune Cells for T1D

$791,321
Everett Meyer · Stanford University · R01 · FY2022 · DK

Intrarenal B cells in acute kidney allograft rejection

$791,315
Anita S. Chong · University Of Chicago · R01 · FY2024 · AI

Intrarenal B cells in acute kidney allograft rejection

$791,315
Anita S. Chong · University Of Chicago · R01 · FY2020 · AI

Intrarenal B cells in acute kidney allograft rejection

$791,315
Anita S. Chong · University Of Chicago · R01 · FY2022 · AI

Intrarenal B cells in acute kidney allograft rejection

$791,315
Anita S. Chong · University Of Chicago · R01 · FY2021 · AI

Intrarenal B cells in acute kidney allograft rejection

$791,315
Anita S. Chong · University Of Chicago · R01 · FY2023 · AI

Regulation Of The Immune Response By The Inositol Phosphatase SHIP

$791,260
Silvia Bolland · Niaid Extramural Activities · Z01 · FY2007 · AI

MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes

$791,237
Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2022 · AI

Collaborative multi-site project to speed the identification and management of rare genetic immune diseases

$791,219
Manish J Butte · University Of California Los Angeles · R01 · FY2024 · AI

TNFR1 in the regulation of autoinflammatory diseases

$791,146
Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2014 · AR

TNF-receptors and programmed cell death in regulation of autoimmunity

$791,146
Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2014 · AR

Role of the microenvironment in regulating early stages of thymic involution and central tolerance

$790,921
Lauren Ilyse Richie Ehrlich · University Of Arizona · P01 · FY2023 · AG

Long Acting Beta Interferon for Treating Multiple Sclerosis - Phase II Continuing

$790,800
George Norbert Cox · Bolder Biotechnology, Inc. · R44 · FY2009 · NS

Signal Transduction In B Lymphocytes: Identification Of Key Signaling Molecules

$790,324
John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Novel Biomarkers and Prediction Models for Rheumatoid Arthritis

$790,317
Elizabeth W Karlson · Brigham And Women'S Hospital · R01 · FY2016 · AR

Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases

$790,309
Stephen I Katz · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA

Metabolic targeting of CD4 T cells in CNS autoimmunity

$790,222
Russell Jones · Van Andel Research Institute · R01 · FY2025 · AI

Determining role of 14-3-3zeta in IL-17A signaling

$790,019
Ritu Chakravarti · University Of Toledo Health Sci Campus · R01 · FY2024 · AI

Robust allograft tolerance in non-human primates

$789,995
Megan Sykes · Columbia University Health Sciences · R01 · FY2016 · OD

Robust allograft tolerance in non-human primates

$789,995
Megan Sykes · Columbia University Health Sciences · R01 · FY2019 · OD

Robust allograft tolerance in non-human primates

$789,995
Megan Sykes · Columbia University Health Sciences · R01 · FY2018 · OD

Approaches for engineering transcriptional state of fibroblasts and other differentiated cell types

$789,739
Thomas Maxwell Norman · Sloan-Kettering Inst Can Research · R01 · FY2025 · HG

Identification and Characterization of Microbial Metabolites in Immunity

$789,624
Ramnik J Xavier · Broad Institute, Inc. · R01 · FY2025 · AI